Erratum: Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis.

de Jesus, Victor Hugo Fonseca; Riechelmann, Rachel P

de Jesus, Victor Hugo Fonseca; Riechelmann, Rachel P.

Afiliación

de Jesus VHF; Medical Oncology Department, A.C. Camargo Cancer Center, Rua Prof. Antônio Prudente 211, São Paulo SP 01509-010, Brazil.
Riechelmann RP; Medical Oncology Department, A.C. Camargo Cancer Center, Rua Prof. Antônio Prudente 211, São Paulo SP 01509-010, Brazil.

Ecancermedicalscience ; 15: 1305, 2021.

Article en En | MEDLINE | ID: mdl-34824628

ABSTRACT

ABSTRACT

[This corrects the article on p. 1 in vol. 15.].

Palabras clave

FOLFIRINOX; adjuvant; cancer; capecitabine; gemcitabine; nab-paclitaxel; pancreatic

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Ecancermedicalscience Año: 2021 Tipo del documento: Article País de afiliación: Brasil

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google